Comtex
Results: 22
| # | Item |
|---|---|
21 | Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease CRANBURY, N.J., June 3, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Amicus Therapeutics (Nasdaq: FOLD), a biopharmaceutical companyAdd to Reading ListSource URL: www.unitedpompe.comLanguage: English - Date: 2008-06-03 09:27:22 |
22 | Biodel Inc. Announces VIAject(TM) Data at Oral Presentation at the American Diabetes Association Meeting DANBURY, Conn., June 22, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) todayAdd to Reading ListSource URL: files.shareholder.comLanguage: English |